PureTech Health (PRTC) Debt to Equity (2020 - 2022)

PureTech Health (PRTC) has 3 years of Debt to Equity data on file, last reported at $0.01 in Q4 2022.

• Quarterly Debt to Equity fell 62.67% year-over-year to $0.01 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $0.01 (down 62.67% YoY) and the FY2022 annual result came in at $0.01, down 62.67% from the prior year.
• Debt to Equity eased to $0.01 in Q4 2022 per PRTC's latest filing, from $0.03 in the prior quarter.
• Across five years, Debt to Equity topped out at $0.03 in Q4 2021 and bottomed at $0.01 in Q4 2022.
• The 3-year median for Debt to Equity is $0.02 (2020), against an average of $0.02.
• The widest annual swing landed in 2021, when Debt to Equity climbed 15.13%; it then slumped 62.67% in 2022.
• Tracing PRTC's Debt to Equity over 3 years: stood at $0.02 in 2020, then climbed by 15.13% to $0.03 in 2021, then sank by 62.67% to $0.01 in 2022.
• Per Business Quant, the three latest PRTC Debt to Equity figures stand at $0.01 (Q4 2022), $0.03 (Q4 2021), and $0.02 (Q4 2020).

Peer Comparison